Bispecific Antibody Approved for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
(MedPage Today) -- Credit: CoRus13
The FDA granted accelerated approval to epcoritamab (Epkinly) for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B‑cell lymphoma on Friday....
Source: MedPage Today Public Health - Category: American Health Source Type: news